Psychedelics Pharma giant Eli Lilly enters psychedelics space with AtaiBeckley takeover AtaiBeckley stock rose more than 55% in after-hours trading Wednesday Rowan Dunne2 days ago
Psychedelics Royal Ontario Museum runs psychedelics exhibit until December The museum is making it very clear that it does not advocate for illicit drug use Rowan Dunne3 days ago
Psychedelics MAPS publishes extensive research paper on ibogaine Ibogaine has been employed for healing purposes by Indigenous groups in Africa for centuries Rowan DunneJuly 8, 2026
Psychedelics Athlete ran 500 miles on psychedelic drugs for upcoming documentary Nobody would finance the film because of the substance use, so they made a GoFundMe campaign Rowan DunneJuly 6, 2026
Psychedelics Brazilian researcher finds sustainable ibogaine sources in undisclosed plants Ricardo Marques has been quietly working on this for almost 20 years Rowan DunneJuly 1, 2026
Psychedelics Definium Therapeutics soars on Phase 3 trial win with LSD depression drug The rally follows year-to-date gains of nearly 175% Rowan DunneJune 24, 2026
Psychedelics Canadian MP introduces medical psilocybin access bill This news was well-received by non-profit advocacy groups in the country Rowan DunneJune 17, 2026
Psychedelics Colorado psychedelic church moves out of basement into strip mall This larger space will cater to a congregation that has expanded nearly 10-fold since its founding Rowan DunneJune 16, 2026
Psychedelics INVI MindHealth and ŌURA gauge psychedelic therapy impact among veterans US$4 million in federal funding has been secured for the endeavour Rowan DunneJune 2, 2026
Psychedelics Psilera raises US$8.8M to fight dementia with non-psychoactive psilocybin drug The biotech is preparing for in-human trials with 'PSIL-006' next year Rowan DunneMay 29, 2026